共 50 条
- [41] An alternatively spliced PD-L1 isoform PD-L1△3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy responseCANCER IMMUNOLOGY IMMUNOTHERAPY, 2023, 72 (12) : 4065 - 4075Dioken, Didem NazOzgul, IbrahimYilmazbilek, IremYakicier, Mustafa CengizKaraca, EzgiErson-Bensan, Ayse Elif
- [42] An alternatively spliced PD-L1 isoform PD-L1∆3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy responseCancer Immunology, Immunotherapy, 2023, 72 : 4065 - 4075Didem Naz DiokenIbrahim OzgulIrem YilmazbilekMustafa Cengiz YakicierEzgi KaracaAyse Elif Erson-Bensan
- [43] An alternatively spliced PD-L1 isoform PD-L1Δ3, and PD-L2 expression in breast cancers: implications for eligibility scoring and immunotherapy responseCANCER IMMUNOLOGY IMMUNOTHERAPY, 2023,Dioken, Didem NazOzgul, IbrahimYilmazbilek, IremYakicier, Mustafa CengizKaraca, EzgiErson-Bensan, Ayse Elif
- [44] PD-L1 and PD-L2 Expression in Cervical Cancer: Regulation and Biomarker PotentialFRONTIERS IN IMMUNOLOGY, 2020, 11Rotman, JossieOtter, Leontine A. S. denBleeker, Maaike C. G.Samuels, Sanne S.Heeren, A. MarijneRoemer, Margaretha G. M.Kenter, Gemma G.Zijlmans, Henry J. M. A. A.van Trommel, Nienke E.de Gruijl, Tanja D.Jordanova, Ekaterina S.
- [45] Prognostic impact of PD-L1 and PD-L2 expression in malignant pleural mesotheliomaVIRCHOWS ARCHIV, 2022, 481 (SUPPL 1) : S334 - S334Yagci, S.Tepeoglu, M.Canpolat, E.Bayik, P.Kilic, M.Ozdemir, B. H.
- [46] Upregulation of PD-L1 and PD-L2 in neck node metastases of head and neck squamous cell carcinomaHEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2019, 41 (08): : 2484 - 2491Moratin, JuliusMetzger, KarlSafaltin, AyseHerpel, EstherHoffmann, JuergenFreier, KoljaHess, JochenHorn, Dominik
- [47] Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinomaBMC CANCER, 2019, 19 (1)Zhang, XingmingYin, XiaoxueZhang, HaoranSun, GuangxiYang, YaojingChen, JunruZhu, XudongZhao, PengZhao, JingeLiu, JiandongChen, NiWang, JiaShen, PengfeiZeng, Hao
- [48] Regulation of PD-1, PD-L1, and PD-L2 expression during normal and autoimmune responsesEUROPEAN JOURNAL OF IMMUNOLOGY, 2003, 33 (10) : 2706 - 2716Liang, SCLatchman, YEBuhlmann, JETomczak, MFHorwitz, BHFreeman, GJSharpe, AH
- [49] Differential expressions of PD-1, PD-L1 and PD-L2 between primary and metastatic sites in renal cell carcinomaBMC Cancer, 19Xingming ZhangXiaoxue YinHaoran ZhangGuangxi SunYaojing YangJunru ChenXudong ZhuPeng ZhaoJinge ZhaoJiandong LiuNi ChenJia WangPengfei ShenHao Zeng
- [50] Interferon Receptor Signaling Pathways Regulating PD-L1 and PD-L2 ExpressionCELL REPORTS, 2017, 19 (06): : 1189 - 1201Garcia-Diaz, AngelShin, Daniel SanghoonMoreno, Blanca HometSaco, JustinEscuin-Ordinas, HelenaRodriguez, Gabriel AbrilZaretsky, Jesse M.Sun, LuHugo, WillyWang, XiaoyanParisi, GiuliaSaus, Cristina PuigTorrejon, Davis Y.Graeber, Thomas G.Comin-Anduix, BegonyaHu-Lieskovan, SiwenDamoiseaux, RobertLo, Roger S.Ribas, Antoni